13F filing recap · Q3 2024
What did Engaged Capital buy in Q3 2024?
Reported stock-position changes between this filing and the previous one.
Stock value
$616.54M
Positions
9
Estimated turnover
41.1%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Engaged Capital opened a new position in Blackline and exited Envestnet, Shake Shack, Smartsheet, and Upbound Group. The firm also trimmed Evolent Health slightly, while adding to Ncr Voyix, Ncr Atleos, Nevro, and Brc. Its most notable increase was in Portillo's, which it added to dramatically.